Delvens published a new research publication on "Drug Discovery Market Insights, to 2030" with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Drug Discovery Market was mainly driven by the increasing R&D spending across the world.
Drug Discovery Market size was estimated at USD 17.3 billion in 2023 and is projected to reach USD 56.8 billion in 2030 at a CAGR of 15.1% during the forecast period 2024-2030.
Get Free Sample Report: https://www.delvens.com/report/drug-discovery-market
The drug discovery market is experiencing robust growth driven by several key factors shaping the pharmaceutical and biopharmaceutical industries globally. A primary driver is the increasing incidence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, which necessitates the development of novel and more effective drugs. This trend is further bolstered by the shift towards personalized medicine, where treatments are tailored to individual genetic profiles, enhancing treatment efficacy and patient outcomes.
Key Findings:
· On the basis of Drug Type, the differentiation between small molecule drugs and biologic drugs is pivotal for driving growth in the drug discovery market. Small molecule drugs, synthesized chemically, have been foundational in treating a wide array of diseases due to their ability to penetrate cell membranes and target intracellular pathways effectively.
· On the basis of Technology, the integration of advanced technologies such as high throughput screening, pharmacogenomics, combinatorial chemistry, nanotechnology, and others is pivotal in driving the growth of the drug discovery market.
· On the basis of type, the end-user segment comprising pharmaceutical companies, contract research organizations (CROs), biotechnology firms, and academic/research institutions collectively drives growth in the drug discovery market through distinct contributions.
North America to Dominate the Market
North America holds the largest share of the global drug discovery market, commanding approximately 40% of the market. This region is distinguished by its robust pharmaceutical industry, characterized by major companies that invest significantly in research and development. The presence of world-renowned academic and research institutions further enhances North America's leadership in drug discovery, facilitating extensive collaboration and innovation.
Competitive Landscape
· Pfizer Inc.
· Novartis AG
· Merck & Co., Inc.
· Johnson & Johnson
· Roche Holding AG
· Sanofi
· AstraZeneca plc
· GlaxoSmithKline plc
· Bristol-Myers Squibb Company
· Eli Lilly and Company
· AbbVie Inc.
· Amgen Inc.
· Biogen Inc.
· Gilead Sciences, Inc.
· Regeneron Pharmaceuticals, Inc.
· Vertex Pharmaceuticals Incorporated
· Takeda Pharmaceutical Company Limited and More
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/drug-discovery-market
Recent Developments
In October 2022, Verge Genomics, a biotechnology company at the clinical stage leveraging AI and human data to revolutionize drug discovery, has initiated dosing the first participant in its Phase 1 clinical trial for VRG50635.
In August 2022, NGM Bio unveiled the top-line findings from the CATALINA Phase 2 Trial of NGM621, targeting patients with geographic atrophy (GA) due to age-related macular degeneration.
The Drug Discovery Market is segmented into various segments such as Drug Type, Technology & End-User, and Region:
Based on Drug Type
· Small Molecule Drugs
· Biologic Drugs
Based on the Technology
· High Throughput Screening
· Pharmacogenomics
· Combinatorial Chemistry
· Nanotechnology
Based on the End-User
· Pharmaceutical Companies
· Contract Research Organizations (CROs)
The Report helps to identify the opportunities in Global Regions:
· North America (the United States, Canada, and Mexico)
· Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
· Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
· South America (Brazil etc.)
· The Middle East and Africa (North Africa and GCC Countries)
Access Full Report: https://www.delvens.com/report/drug-discovery-market
In addition to the market data for the Drug Discovery Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements.
Frequently Asked Questions
· What are the years considered to study Drug Discovery Market intelligence report?
· What is the compound annual growth rate (CAGR) of the Drug Discovery Market?
· Which region holds the largest market share in Drug Discovery Market?
· Which region is the fastest growing in Drug Discovery Market?
· Who are the major players in Drug Discovery Market?
More Reports from Delvens:
Antibody Drug Conjugates (ADC) market size was estimated at USD 5.78 billion in 2023 and is projected to reach USD 24.53 billion in 2030 at a CAGR of 22.94% during the forecast period 2023-2030.
Active Pharmaceutical Ingredient (API) Market size was estimated at USD 165.7 billion in 2023 and is projected to reach USD 241.5 billion in 2030 at a CAGR of 8.1% during the forecast period 2024-2030.
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
